Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0854359
Disease: Insulin autoimmune syndrome
Insulin autoimmune syndrome
0.070 GeneticVariation disease BEFREE We found a potential new predisposing factor for HD, HLA DRB1*0415 allele, never described before as genetic background to insulin autoimmune syndrome in Caucasians. 31734778 2020
CUI: C0854359
Disease: Insulin autoimmune syndrome
Insulin autoimmune syndrome
0.070 Biomarker disease BEFREE Both cases are associated with HLA-DRB1*04:03 and confirm the evidence that HLA-DRB1*04:03 rather than HLA-DRB1*04:06 is specifically related to IAS susceptibility in Europeans. 30086435 2019
CUI: C0854359
Disease: Insulin autoimmune syndrome
Insulin autoimmune syndrome
0.070 Biomarker disease BEFREE These two Portuguese patients with IAS had different HLA-DR4 subtypes and insulin autoantibodies: DRB1*0406 and a polyclonal antibody in a patient treated with penicillin, and DRB1*0403 and a monoclonal antibody in a patient with "idiopathic" IAS. 11517012 2001
CUI: C0854359
Disease: Insulin autoimmune syndrome
Insulin autoimmune syndrome
0.070 GeneticVariation disease BEFREE The present report demonstrated the first Japanese patient with insulin autoimmune syndrome carrying HLA-DRB1*0401 who was revealed to have monoclonal insulin autoantibodies. 11182636 2000
CUI: C0854359
Disease: Insulin autoimmune syndrome
Insulin autoimmune syndrome
0.070 GeneticVariation disease BEFREE The extremely low prevalence of IAS among Caucasians can be explained by the low prevalence of DRB1*0406 in this population. 10717808 2000
CUI: C0854359
Disease: Insulin autoimmune syndrome
Insulin autoimmune syndrome
0.070 GeneticVariation disease BEFREE Because of such a strong HLA association in IAS, we performed intra- and interethnic studies on IAS-associated DRB1 alleles and searched for the critical amino acid residue(s) for IAS pathogenesis. 7556962 1995
CUI: C0854359
Disease: Insulin autoimmune syndrome
Insulin autoimmune syndrome
0.070 Biomarker disease BEFREE Thus, it is highly likely that patients with Graves' disease develop IAS via treatment with methimazole when their Bw62/Cw4/DR4 carry DRB1*0406. 8325948 1993